Concepedia

Stephen Y. W. Lau

SY

Statistics

Publications

14

Citations

675

H-Index

14

Active since

1999

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

University of Calgary

Merck Canada Inc. (Canada)

University of British Columbia

Stephen Y. W. Lau is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in drug discovery, medicine, and pharmacology.

Top concepts

Publications per year

1999–2015

14

Publications

14

Loblolly pine abietadienol/abietadienal oxidase <i>PtAO</i> (CYP720B1) is a multifunctional, multisubstrate cytochrome P450 monooxygenase

Dae‐Kyun Ro, Gen‐ichiro Arimura, Stephen Y. W. Lau et al. · Proceedings of the National Academy of Sciences · 2005 · 183 citations · Full text

CRTH2 Antagonist MK-7246: A Synthetic Evolution from Discovery through Development

Carmela Molinaro, Paul G. Bulger, Ernest E. Lee et al. · The Journal of Organic Chemistry · 2012 · 119 citations

Discovery of MK-7246, a selective CRTH2 antagonist for the treatment of respiratory diseases

Michel Gallant, Christian Beaulieu, Carl Berthelette et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 49 citations · Full text

, , +5

Magnesiation of Electron-Rich Aryl Bromides and Their Use in Nickel-Catalyzed Cross-Coupling Reactions

Stephen Y. W. Lau, G. Hughes, Paul O’Shea et al. · Organic Letters · 2007 · 41 citations

A Practical Synthesis of 5-Lipoxygenase Inhibitor MK-0633

Francis Gosselin, Robert Britton, Ian W. Davies et al. · The Journal of Organic Chemistry · 2010 · 40 citations

, , +15

1–5 of 14